HF affects approximately 6.2 million adults in the US. Mortality in patients with HF is high and is even higher for patients with advanced HF. Treatment plans for these patients include interventions to not only improve survival but to also improve HRQOL.
This study used data from the Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support (SUSTAIN-IT) study. Patients were classified into 3 groups: HT candidates with MCS, HT candidates without MCS, and candidates not eligible for HT and scheduled for long-term MCS. Study participants complete assessments on self-reported measures of HRQOL, depressive symptoms, anxiety, cognitive status, and performance-based measures.
Results and Conclusions
The study included 393 patients, with a majority of participants being White men. Long-term MCS candidates had worse HRQOL than HT candidates, irrespective of MCS status. After multiple variable adjustments, researchers found that the following factors were associated with worse overall HRQOL: lower 6-minute walk distance, higher New York Heart Association class, depressive symptoms, and not being an HT candidate with MCS.
Consider these findings from similar research studies:
HRQOL improved from before implantation to 2 years after MCS implant, irrespective of implant strategy (Source).
HRQOL is a predictor of long-term cardiac death in older patients hospitalized with HF (Source).